Author:
Averbach Andrew M.,Sugarbaker Paul H.
Reference80 articles.
1. Cutler SJ, Young JC. Third National Cancer Study Incidence Data, Vol 41. Bethesda, MD: National Cancer Institute, 1975, p 442.
2. Vogelganz NJ, Schultz SM, Ianucci AM, Kennedy BJ. Malignant mesothelioma. The University of Minnesota experience. Cancer 1984;53:377–383.
3. Connely RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF. Demographic patterns for mesothelioma in United States. J Nate Cancer Inst 1987;78:1053.
4. Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980;68:356–362.
5. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J. Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 1988;6:147–153.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献